- Stocks
- Healthcare
- NYSE: CHE

Price (delayed)

$527.115

Market cap

$7.88B

P/E Ratio

31.53

Dividend/share

$1.5

EPS

$16.72

Enterprise value

$7.94B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of

Chemed's quick ratio has soared by 67% from the previous quarter and by 29% YoY

The debt is down by 45% since the previous quarter and by 39% year-on-year

The price to earnings (P/E) is 14% higher than the last 4 quarters average of 27.6 and 13% higher than the 5-year quarterly average of 27.8

The net income has declined by 7% year-on-year and by 4.8% since the previous quarter

What are the main financial stats of CHE

Market
Valuations
Earnings

Shares outstanding

14.95M

Market cap

$7.88B

Enterprise value

$7.94B

Price to earnings (P/E)

31.53

Price to book (P/B)

9.81

Price to sales (P/S)

3.69

EV/EBIT

23.76

EV/EBITDA

20.19

EV/Sales

3.72

Revenue

$2.13B

EBIT

$334.26M

EBITDA

$393.44M

Free cash flow

$254.89M

Per share
Balance sheet
Liquidity

EPS

$16.72

Free cash flow per share

$17.07

Book value per share

$53.71

Revenue per share

$143.01

TBVPS

$50.97

Total assets

$1.44B

Total liabilities

$643.3M

Debt

$136.5M

Equity

$798.72M

Working capital

-$24.59M

Debt to equity

0.17

Current ratio

0.92

Quick ratio

0.72

Net debt/EBITDA

0.16

Margins
Efficiency
Dividend

EBITDA margin

18.4%

Gross margin

35.8%

Net margin

11.7%

Operating margin

16.1%

Return on assets

18.4%

Return on equity

34.8%

Return on invested capital

57.5%

Return on capital employed

29.2%

Return on sales

15.7%

Dividend yield

0.28%

DPS

$1.5

Payout ratio

9%

How has the Chemed stock price performed over time

Intraday

0.19%

1 week

2.14%

1 month

2.78%

1 year

8.57%

YTD

3.27%

QTD

3.27%

How have Chemed's revenue and profit performed over time

Revenue

$2.13B

Gross profit

$765.09M

Operating income

$343.5M

Net income

$249.62M

Gross margin

35.8%

Net margin

11.7%

The net margin is down by 7% year-on-year and by 4.9% since the previous quarter

The net income has declined by 7% year-on-year and by 4.8% since the previous quarter

The operating margin has decreased by 4.7% QoQ

Chemed's operating income has decreased by 4.6% from the previous quarter

What is Chemed's growth rate over time

What is Chemed stock price valuation

P/E

31.53

P/B

9.81

P/S

3.69

EV/EBIT

23.76

EV/EBITDA

20.19

EV/Sales

3.72

The price to earnings (P/E) is 14% higher than the last 4 quarters average of 27.6 and 13% higher than the 5-year quarterly average of 27.8

The EPS has decreased by 4% from the previous quarter and by 2.5% YoY

Chemed's equity has increased by 28% YoY and by 11% from the previous quarter

The P/B is 3.2% more than the 5-year quarterly average of 9.5 but 2% less than the last 4 quarters average of 10.0

How efficient is Chemed business performance

The company's return on invested capital fell by 24% YoY and by 2.9% QoQ

The ROE has contracted by 11% from the previous quarter but it has grown by 3.9% YoY

The ROA has declined by 7% since the previous quarter and by 6% year-on-year

The ROS has decreased by 4.8% YoY and by 3.7% from the previous quarter

What is CHE's dividend history

DPS

$1.5

Dividend yield

0.28%

Payout ratio

9%

Recent dividends

How did Chemed financials performed over time

Chemed's total assets is 124% higher than its total liabilities

Chemed's quick ratio has soared by 67% from the previous quarter and by 29% YoY

CHE's current ratio is up by 37% from the previous quarter and by 21% YoY

The debt is 83% smaller than the equity

CHE's debt to equity has dropped by 53% year-on-year and by 50% since the previous quarter

The debt is down by 45% since the previous quarter and by 39% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.